Article info

Download PDFPDF
Original research
Bleeding risk with rivaroxaban compared with vitamin K antagonists in patients aged 80 years or older with atrial fibrillation

Authors

  1. Correspondence to Professor Olivier Hanon, Service de Gérontologie, Hôpital Broca, 75013 Paris, France; olivier.hanon{at}aphp.fr
View Full Text

Citation

Hanon O, Vidal J, Pisica-Donose G SAFIR study group, et al
Bleeding risk with rivaroxaban compared with vitamin K antagonists in patients aged 80 years or older with atrial fibrillation

Publication history

  • Received July 29, 2020
  • Revised October 19, 2020
  • Accepted October 21, 2020
  • First published December 1, 2020.
Online issue publication 
August 12, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.